FDA Application
-
NDC Search Results on Active Ingredient: bosentan
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
BOSENTAN | 0591-2511-60 | Actavis Pharma, Inc. | ANDA207110 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 0591-2512-60 | Actavis Pharma, Inc. | ANDA207110 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-038-60 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-038-64 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-038-86 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-039-60 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-039-64 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-039-86 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN ANHYDROUS | 65162-873-06 | Amneal Pharmaceuticals LLC | ANDA209742 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN ANHYDROUS | 65162-874-06 | Amneal Pharmaceuticals LLC | ANDA209742 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 66215-101-03 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-101-06 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-102-03 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-102-06 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-103-14 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-103-56 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-232-14 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-232-56 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 68382-446-01 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-446-05 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-446-14 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-446-28 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-446-30 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-446-77 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-447-01 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-447-05 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-447-14 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-447-28 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-447-30 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 68382-447-77 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
1-30 | 31-42 |
-